Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII

被引：0
|
作者：
Guillet, B [1 ]
Pinganaud, C
Proulle, V
Dreyfus, M
Lambert, T
机构：
[1] Hop Bicetre, AP HP, Ctr Traitement Malad Hemorrag, F-94275 Le Kremlin Bicetre, France
[2] Hop Bicetre, AP HP, Hematol Lab, F-94275 Le Kremlin Bicetre, France
[3] Hop Bicetre, AP HP, Serv Med Interne, F-94275 Le Kremlin Bicetre, France
[4] Fac Med Paris XI, Le Kremlin Bicetre, France
来源：
THROMBOSIS AND HAEMOSTASIS | 2002年 / 88卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：698 / 699
页数：2
相关论文
共 50 条
  • [21] Acute myocardial infarction during substitution with recombinant factor VIII concentrate in a patient with mild haemophilia A
    Kerkhoffs, JL
    Atsma, DE
    Oemrawsingh, PV
    Eikenboom, J
    Van der Meer, FJM
    THROMBOSIS AND HAEMOSTASIS, 2004, 92 (02) : 425 - 426
  • [22] Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma
    Holcomb, JB
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 58 (06): : 1298 - 1303
  • [23] Alternating Activated Prothrombin Complex Concentrate and Recombinant Activated Factor VII in the Successful Treatment of Patients with Acquired Hemophilia A
    Gavva, Chakri
    Hofmann, Sandra L.
    Rambally, Siayareh
    Shen, Yu-Min
    De Simone, Nicole
    Sarode, Ravi
    BLOOD, 2016, 128 (22)
  • [24] The treatment of bleeding in acquired haemophilia with recombinant factor VIIa.
    Hay, CRM
    Ludlam, CA
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 230 - 230
  • [25] Treatment of obstetric hemorrhage with recombinant activated factor VII
    P Czuprynski
    G Michalska
    Critical Care, 13 (Suppl 1):
  • [26] RADIONUCLIDE EVALUATION OF RENAL THROMBOEMBOLIC EVENT DURING TREATMENT WITH RECOMBINANT ACTIVATED FACTOR VII IN A CHILD WITH HAEMOPHILIA B WITH PLASMA IX INHIBITORS
    Spajic, Marija
    Milosevic, Danko
    Batinic, Danica
    Poropat, Mirjana
    Galic, Slobodan
    Turudic, Daniel
    Bilic, Ernest
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1569 - 1569
  • [27] Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases
    Di Capua, Mirko
    Coppola, Antonio
    Nardo, Assunta
    Cimino, Ernesto
    Di Minno, Matteo N. D.
    Tufano, Antonella
    Mormile, Rosaria
    Burzo, Maria L.
    Di Minno, Giovanni
    Cerbone, Anna M.
    BLOOD TRANSFUSION, 2015, 13 (02) : 328 - 332
  • [28] Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors
    Santagostino, Elena
    Escobar, Miguel
    Ozelo, Margareth
    Solimeno, Luigi
    Arkhammar, Per
    Lee, Hye Youn
    Rosu, Gabriela
    Giangrande, Paul
    BLOOD REVIEWS, 2015, 29 : S9 - S18
  • [29] Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: A case report
    Kubisz, Peter
    Plamenova, Ivana
    Stasko, Jan
    Dobrotova, Miroslava
    Holly, Pavol
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (04) : 868 - 870
  • [30] Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven®) in children vs adults with haemophilia A
    Villar, A
    Aronis, S
    Morfini, M
    Santagostino, E
    Auerswald, G
    Thomsen, HF
    Erhardtsen, E
    Giangrande, PLF
    HAEMOPHILIA, 2004, 10 (04) : 352 - 359
12345